alkermes plc (ALKS:NASDAQ GS)
Floyd E. Bloom M.D.
Co-Founder, Director and Member of Audit & Risk Committee, Alkermes plc
|Age||Total Calculated Compensation||This person is connected to 92 board members in 9 different organizations across 6 different industries.|
See Board Relationships
Dr. Floyd E. Bloom, M.D. is a Co-Founder of Alkermes Inc. Dr. Bloom served as the Chairman and Chief Executive Officer of Neurome Inc. Dr. Bloom has been active in Neuropharmacology for more than 35 years, holding positions at Yale University, the National Institute of Mental Health and The Salk Institute. He has investigated comprehensive eneurotransmitter systems at the anatomical, physiological, and pharmacological levels. Dr. Bloom has conducted correlative studies ...
Connaught HousePhone: 353 1 772 8000
Dublin, Co. Dublin 4
Board Members Memberships*
Former Member of Science & Technology Committee
Co-Founder, Director and Member of Audit & Risk Committee
Southern Methodist University
Washington University School of Medicine
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
|David M. Stack||Chairman, Chief Executive Officer and President|
Pacira Pharmaceuticals, Inc.
|George Frederick Wilkinson||Chief Executive Officer, President and Director|
Impax Laboratories Inc.
|Thomas W. D'Alonzo Esq., J.D.||Chairman, Acting Chief Executive Officer, Acting President, Member of Audit Committee, Member of Nominating/Corporate Governance Committee and Member of Compensation Committee|
Salix Pharmaceuticals Ltd.
|Arun Sawhney B.Com., P.G.D.B.M.||Chief Executive Officer, Managing Director, Executive Director, Member of Shareholders/Investors Grievance & Share Transfer Committee, Member of Quality & Integrity Committee, Member of Science Committee and Member of Corporate Social Responsibility Committee|
Ranbaxy Laboratories Ltd.
|Bruce C. Cozadd||Co-Founder, Executive Chairman and Chief Executive Officer|
Jazz Pharmaceuticals Public Limited Company
|$771.2K||Compensation as of Fiscal Year 2013.|